Question 1

What is DexCom's P/S ratio?

Accepted Answer

DexCom (DXCM) P/S ratio is 5.8× as of July 22, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month revenue, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/S ratio calculated?

Accepted Answer

P/S = Market Capitalisation ÷ Trailing Twelve-Month (TTM) Revenue, or equivalently Share Price ÷ TTM Revenue Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/S ratio?

Accepted Answer

The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.

Question 4

What is a good P/S ratio for DexCom?

Accepted Answer

A "good" P/S depends heavily on profit margin and growth: software and other high-margin businesses often command 5–15× sales, while low-margin retailers and commodity producers typically trade below 1×. Compare against sector peers rather than absolute thresholds. For DexCom specifically, the relevant sector benchmark is the current sector median of 3.4×.

Question 5

Is DexCom's P/S ratio high or low?

Accepted Answer

DexCom's P/S ratio of 5.8× is below its own 5-year average of 12.4× and above the sector median of 3.4×. That places the current reading at the 7th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is DexCom's historical P/S ratio range?

Accepted Answer

In the available daily series, DexCom (DXCM) P/S ratio has ranged from a low of 4.7× in 2026 to a high of 35078.7× in 2006. The 5-year average is 12.4× and the 5-year median is 11.7×.

Question 7

What was DexCom's P/S ratio in 2025?

Accepted Answer

DexCom (DXCM) P/S ratio at the end of 2025 was 5.5×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month revenue figure available at that date.

Question 8

Why does DexCom's P/S ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (revenue). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$25.7B	$4.66B	5.5×	-2.2×	Dec 31, 2025
2024	$31.1B	$4.03B	7.7×	-5.5×	Dec 31, 2024
2023	$47.7B	$3.62B	13.2×	-1.9×	Dec 31, 2023
2022	$43.7B	$2.91B	15.0×	-6.2×	Dec 31, 2022
2021	$52.1B	$2.45B	21.3×	+3.2×	Dec 31, 2021
2020	$34.9B	$1.93B	18.1×	+4.5×	Dec 31, 2020
2019	$20B	$1.48B	13.6×	+3.3×	Dec 31, 2019
2018	$10.6B	$1.03B	10.3×	+3.5×	Dec 31, 2018
2017	$4.86B	$719M	6.8×	-2.1×	Dec 31, 2017
2016	$5.05B	$573M	8.8×	-7.8×	Dec 31, 2016
2015	$6.67B	$402M	16.6×	+0.3×	Dec 31, 2015
2014	$4.23B	$259M	16.3×	+0.6×	Dec 31, 2014
2013	$2.52B	$160M	15.7×	+6.4×	Dec 31, 2013
2012	$934M	$99.9M	9.4×	+1.3×	Dec 31, 2012
2011	$611M	$76.3M	8.0×	-7.9×	Dec 31, 2011
2010	$776M	$48.6M	16.0×	+3.9×	Dec 31, 2010
2009	$358M	$29.7M	12.1×	+3.8×	Dec 31, 2009
2008	$81.6M	$9.84M	8.3×	-45.8×	Dec 31, 2008
2007	$250M	$4.63M	54.1×	-69.9×	Dec 31, 2007
2006	$269M	$2.17M	124.0×	—	Dec 31, 2006
2005	$283M	$0.00	—	—	Dec 31, 2005


Zimmer Biomet Holdings (ZBH)	2.1×
AptarGroup (ATR)	2.1×
Becton, Dickinson and (BDX)	2.1×
Charles River (CRL)	1.9×
Quest Diagnostics (DGX)	1.9×
IQVIA (IQV)	1.7×
GE HealthCare (GEHC)	1.6×
Labcorp Holdings (LH)	1.6×
HCA Healthcare (HCA)	1.4×
Solventum (SOLV)	1.4×
Viatris (VTRS)	1.1×
UnitedHealth Group (UNH)	0.8×
Baxter International (BAX)	0.8×
DaVita (DVA)	0.7×
Henry Schein (HSIC)	0.6×
Universal Health Services (UHS)	0.6×
Elevance Health (ELV)	0.4×
Teladoc Health (TDOC)	0.4×
McKesson (MCK)	0.3×
Cigna (CI)	0.3×
CVS Health (CVS)	0.2×
Cardinal Health (CAH)	0.2×
Cencora (COR)	0.2×
Humana (HUM)	0.2×
Centene (CNC)	0.1×

P/S Ratio for DexCom (DXCM) 2006-2026

P/S Ratio daily chart for DexCom (DXCM)

Historical P/S Ratio for DexCom (DXCM) from 2005 to 2025

About P/S Ratio at DexCom (DXCM)

DexCom P/S Ratio by Year

DexCom P/S Ratio 2025: 5.5×

DexCom P/S Ratio 2024: 7.7×

DexCom P/S Ratio 2023: 13.2×

DexCom P/S Ratio 2022: 15.0×

DexCom P/S Ratio 2021: 21.3×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

DexCom (DXCM) Key Financials